5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylic acid;5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethyl-N-(2,2,2-trifluoroethyl)indolizine-8-carboxamide;methyl 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylate;2,2,2-trifluoroethanamine

C68H53Cl6F15N8O8 — CID 160645412

IUPAC5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylic acid;5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethyl-N-(2,2,2-trifluoroethyl)indolizine-8-carboxamide;methyl 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylate;2,2,2-trifluoroethanamine
SMILESCOC(=O)c1ccc(C2=NOC(c3cc(Cl)cc(Cl)c3)(C(F)(F)F)C2)n2c(C)cc(C)c12.Cc1cc(C)n2c(C3=NOC(c4cc(Cl)cc(Cl)c4)(C(F)(F)F)C3)ccc(C(=O)NCC(F)(F)F)c12.Cc1cc(C)n2c(C3=NOC(c4cc(Cl)cc(Cl)c4)(C(F)(F)F)C3)ccc(C(=O)O)c12.NCC(F)(F)F
InChIInChI=1S/C23H17Cl2F6N3O2.C22H17Cl2F3N2O3.C21H15Cl2F3N2O3.C2H4F3N/c1-11-5-12(2)34-18(4-3-16(19(11)34)20(35)32-10-22(26,27)28)17-9-21(36-33-17,23(29,30)31)13-6-14(24)8-15(25)7-13;1-11-6-12(2)29-18(5-4-16(19(11)29)20(30)31-3)17-10-21(32-28-17,22(25,26)27)13-7-14(23)9-15(24)8-13;1-10-5-11(2)28-17(4-3-15(18(10)28)19(29)30)16-9-20(31-27-16,21(24,25)26)12-6-13(22)8-14(23)7-12;3-2(4,5)1-6/h3-8H,9-10H2,1-2H3,(H,32,35);4-9H,10H2,1-3H3;3-8H,9H2,1-2H3,(H,29,30);1,6H2
InChIKeyRJSLCZULIBXWCG-UHFFFAOYSA-N
MW1607.91 g/mol
LogP19.62
Rot. Bonds10

About 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylic acid;5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethyl-N-(2,2,2-trifluoroethyl)indolizine-8-carboxamide;methyl 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylate;2,2,2-trifluoroethanamine

5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylic acid;5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethyl-N-(2,2,2-trifluoroethyl)indolizine-8-carboxamide;methyl 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylate;2,2,2-trifluoroethanamine (PubChem CID 160645412) has the molecular formula C68H53Cl6F15N8O8 and a molecular weight of 1607.91 g/mol. Its IUPAC name is 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylic acid;5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethyl-N-(2,2,2-trifluoroethyl)indolizine-8-carboxamide;methyl 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylate;2,2,2-trifluoroethanamine.

Molecular Properties

Compound Name5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylic acid;5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethyl-N-(2,2,2-trifluoroethyl)indolizine-8-carboxamide;methyl 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylate;2,2,2-trifluoroethanamine
PubChem CID160645412
Molecular FormulaC68H53Cl6F15N8O8
Molecular Weight1607.91 g/mol
Exact Mass1604.19
IUPAC Name5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylic acid;5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethyl-N-(2,2,2-trifluoroethyl)indolizine-8-carboxamide;methyl 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylate;2,2,2-trifluoroethanamine
SMILESCOC(=O)c1ccc(C2=NOC(c3cc(Cl)cc(Cl)c3)(C(F)(F)F)C2)n2c(C)cc(C)c12.Cc1cc(C)n2c(C3=NOC(c4cc(Cl)cc(Cl)c4)(C(F)(F)F)C3)ccc(C(=O)NCC(F)(F)F)c12.Cc1cc(C)n2c(C3=NOC(c4cc(Cl)cc(Cl)c4)(C(F)(F)F)C3)ccc(C(=O)O)c12.NCC(F)(F)F
InChIInChI=1S/C23H17Cl2F6N3O2.C22H17Cl2F3N2O3.C21H15Cl2F3N2O3.C2H4F3N/c1-11-5-12(2)34-18(4-3-16(19(11)34)20(35)32-10-22(26,27)28)17-9-21(36-33-17,23(29,30)31)13-6-14(24)8-15(25)7-13;1-11-6-12(2)29-18(5-4-16(19(11)29)20(30)31-3)17-10-21(32-28-17,22(25,26)27)13-7-14(23)9-15(24)8-13;1-10-5-11(2)28-17(4-3-15(18(10)28)19(29)30)16-9-20(31-27-16,21(24,25)26)12-6-13(22)8-14(23)7-12;3-2(4,5)1-6/h3-8H,9-10H2,1-2H3,(H,32,35);4-9H,10H2,1-3H3;3-8H,9H2,1-2H3,(H,29,30);1,6H2
InChIKeyRJSLCZULIBXWCG-UHFFFAOYSA-N
XLogP19.62
TPSA196.72 Ų
H-Bond Donors3
H-Bond Acceptors14
Rotatable Bonds10
Heavy Atoms105
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001607.91
LogP ≤ 519.62
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1014

Analyze 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylic acid;5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethyl-N-(2,2,2-trifluoroethyl)indolizine-8-carboxamide;methyl 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylate;2,2,2-trifluoroethanamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylic acid;5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethyl-N-(2,2,2-trifluoroethyl)indolizine-8-carboxamide;methyl 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylate;2,2,2-trifluoroethanamine?
The IUPAC name of 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylic acid;5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethyl-N-(2,2,2-trifluoroethyl)indolizine-8-carboxamide;methyl 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylate;2,2,2-trifluoroethanamine (CID 160645412) is 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylic acid;5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethyl-N-(2,2,2-trifluoroethyl)indolizine-8-carboxamide;methyl 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylate;2,2,2-trifluoroethanamine.
What is the SMILES notation for 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylic acid;5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethyl-N-(2,2,2-trifluoroethyl)indolizine-8-carboxamide;methyl 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylate;2,2,2-trifluoroethanamine?
The canonical SMILES for 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylic acid;5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethyl-N-(2,2,2-trifluoroethyl)indolizine-8-carboxamide;methyl 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylate;2,2,2-trifluoroethanamine is COC(=O)c1ccc(C2=NOC(c3cc(Cl)cc(Cl)c3)(C(F)(F)F)C2)n2c(C)cc(C)c12.Cc1cc(C)n2c(C3=NOC(c4cc(Cl)cc(Cl)c4)(C(F)(F)F)C3)ccc(C(=O)NCC(F)(F)F)c12.Cc1cc(C)n2c(C3=NOC(c4cc(Cl)cc(Cl)c4)(C(F)(F)F)C3)ccc(C(=O)O)c12.NCC(F)(F)F.
What is the InChIKey of 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylic acid;5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethyl-N-(2,2,2-trifluoroethyl)indolizine-8-carboxamide;methyl 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylate;2,2,2-trifluoroethanamine?
The InChIKey is RJSLCZULIBXWCG-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H17Cl2F6N3O2.C22H17Cl2F3N2O3.C21H15Cl2F3N2O3.C2H4F3N/c1-11-5-12(2)34-18(4-3-16(19(11)34)20(35)32-10-22(26,27)28)17-9-21(36-33-17,23(29,30)31)13-6-14(24)8-15(25)7-13;1-11-6-12(2)29-18(5-4-16(19(11)29)20(30)31-3)17-10-21(32-28-17,22(25,26)27)13-7-14(23)9-15(24)8-13;1-10-5-11(2)28-17(4-3-15(18(10)28)19(29)30)16-9-20(31-27-16,21(24,25)26)12-6-13(22)8-14(23)7-12;3-2(4,5)1-6/h3-8H,9-10H2,1-2H3,(H,32,35);4-9H,10H2,1-3H3;3-8H,9H2,1-2H3,(H,29,30);1,6H2.
What are the key properties of 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylic acid;5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethyl-N-(2,2,2-trifluoroethyl)indolizine-8-carboxamide;methyl 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylate;2,2,2-trifluoroethanamine?
5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylic acid;5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethyl-N-(2,2,2-trifluoroethyl)indolizine-8-carboxamide;methyl 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylate;2,2,2-trifluoroethanamine has a molecular weight of 1607.91 g/mol, XLogP of 19.62, 10 rotatable bonds, 3 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylic acid;5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethyl-N-(2,2,2-trifluoroethyl)indolizine-8-carboxamide;methyl 5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-1,3-dimethylindolizine-8-carboxylate;2,2,2-trifluoroethanamine is sourced from PubChem (CID 160645412), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).